Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro

Overview of attention for article published in Frontiers in immunology, March 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 33,780 followers.

RT @FrontImmunol: New Research: Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro: IL-…

08 Mar 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro: IL-…

08 Mar 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro: IL-…

07 Mar 2024

Reply Repost Favourite

New Research: Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro: IL-15 has shown preclinical activity by enhancing the functional maturation of natural killer (NK) cells. Clinical… https://t.co/FVLciy9Tx

07 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.